Suscribirse

PSYCHOLOGIC FACTORS AND PATIENT ADHERENCE - 03/09/11

Doi : 10.1016/S0889-8561(05)70229-0 
Henry Milgrom, MD a, b, Bruce Bender, PhD a, Frederick Wamboldt, MD b
a Departments of Pediatrics (HM, BB) 
b Medicine (HM, FW), National Jewish Medical and Research Center; and the University of Colorado Health Sciences Center, Denver, Colorado 

Resumen

Clinical practice guidelines have been issued to assist physicians in choosing the most appropriate and effective medications to improve patient outcomes.33 Most of these guidelines explicitly acknowledge that the success of medical therapy depends on the efficacy of the recommended treatment and the patient's adherence with that regimen. Adherence may be defined as the extent to which the patient's actual practice corresponds to the prescribed regimen.75 For ambulatory patients, adherence constitutes the link between medical process and treatment outcome.75 The goals of asthma management set down by two Expert Panel Reports under the auspices of the National Heart, Lung, and Blood Institute (NHLBI) are to (1) treat the patient with the least aggressive therapy sufficient to prevent chronic symptoms and exacerbations, (2) maintain normal activity and normal or near-normal lung function, (3) avoid missing school or work, and (4) eliminate sleep disruption.51, 52 The recommended treatment is organized around four components: (1) step-wise pharmacologic therapy adjusted to the severity of the patient's disease, (2) use of objective measures of lung function, (3) environmental control, and (4) patient education to advance a partnership among the patient, family, and clinicians.51, 52 The intent of the final component is to promote adherence fundamental to the success of the other three components. Accordingly, the step-wise approach to therapy recommended by these Expert Panel Reports can only succeed if there is adequate adherence by both physicians and patients.

The goals of the Expert Panels are not being met (Table 1). Asthma continues to be a leading cause of preventable hospitalization in the United States with 470,000 admissions and more than 5000 deaths a year.55 Fewer than half of the children who need emergency room treatment28 and adults who require hospitalization35 receive the anti-inflammatory therapy advocated by the Expert Panel Report-2,52 a deplorable neglect given that the use of low-dose inhaled corticosteroids is associated with a decreased risk of death from asthma (Figure 1).73

Estimates of adherence rates to therapeutic recommendations in long-term medical regimens range between 50% and 65%.46 For children with asthma, the average medication adherence rate of 48% was found in a review of 10 studies,20 and similar findings have been reported for adult patients.59, 69 One publication demonstrates that adolescents with diabetes who agree to participate in studies have a higher rate of adherence than those who do not.61 The accepted figures for adherence, though disappointing, may be overly optimistic.

El texto completo de este artículo está disponible en PDF.

Esquema


 Address reprint requests to Henry Milgrom, MD, National Jewish Medical and Research Center, 1400 Jackson Street, Denver, CO 80206


© 2001  W. B. Saunders Company. Publicado por Elsevier Masson SAS. Todos los derechos reservados.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 21 - N° 3

P. 589-604 - août 2001 Regresar al número
Artículo precedente Artículo precedente
  • STEROID-RESISTANT ASTHMA
  • Joseph D. Spahn, Ronina Covar

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.

¿Ya suscrito a @@106933@@ revista ?

@@150455@@ Voir plus

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2026 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.